BJ
GEVA

BlackRock Japan’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

BlackRock Japan’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-218
Closed -$21K – 1467
2015
Q1 		$21K Sell
218
-150
-41% -$15.9K ﹤0.01% 1187
2014
Q4 		$34K Buy
368
+262
+247% +$20.7K ﹤0.01% 1153
2014
Q3 		$7K Sell
106
-236
-69% -$16.9K ﹤0.01% 1227
2014
Q2 		$36K Sell
342
-133
-28% -$11.3K ﹤0.01% 1082
2014
Q1 		$39K Buy
+475
New +$43.9K ﹤0.01% 1197

BlackRock Japan's GEVA Position: Q2 2015 in Review

BlackRock Japan sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 218 shares — an estimated $21K sold.

BlackRock Japan first reported a position in GEVA in Q1 2014 and held it in 5 quarters. The position peaked at $39K in Q1 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • BlackRock Japan reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Japan sold 218 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $21K.
  • BlackRock Japan first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • BlackRock Japan's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $39K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on BlackRock Japan's 13F filing for Q2 2015, filed 7 Aug 2015.